You're currently viewing an old version of this dataset. To see the current version, click here.

Malawi Integrated HIV Program Report 2019 Q3

  • Scale-up of integrated HIV services had reached the following number of sites:
    • 759 static and 197 outreach HIV testing sites
    • 750 (static) ART sites; 615 of these started at least one pregnant or breastfeeding woman and 732 started asymptomatic patients (Test & Treat) this quarter
    • 691 sites with HIV-exposed children in follow-up
  • 1,019,610 persons were tested for HIV and received their results; 207,831 (20%) accessed HIV testing for the first time; 811,779 (80%) were repeat testers and 32,190 (4%) of these received confirmatory testing (after having tested positive in the past). 28,376 (2.8%) clients received a positive result for the first time.
  • A total of 30,622 people received 38,444 self-test kits for either primary or secondary use.
  • 14,482 (80%) of 18,018 blood units collected were screened for (at least) HIV, hepatitis B and syphilis
  • 168,033 (98%) of 172,271 women at ANC had their HIV status ascertained; 11,669 (7%) of these were HIV positive. 149,107 (96%) of 155,842 at maternity had their HIV status ascertained 10,904 (7%) of these were HIV positive.
  • 27,624 patients started ART this quarter; 80% were classified as asymptomatic / in WHO stage 1 and started under the “Test & Treat” policy.
  • 826,102 patients were alive and on ART by end of September 2019. This means that 77% of the estimated 1,070,896 HIV positive population were on ART. ART coverage was 69% (46,628/ 67,465) for children and 77% (779,474 / 1,003,432) for adults.
  • 125,766 (93%) of viral load results from routine monitoring were 99%) of an estimated 10,932 3 HIV infected pregnant women in Malawi were on ART this quarter. 9,521(73%) of these were already on ART when getting pregnant and 3,593 (27%)__ started ART during pregnancy/delivery.

Data and Resources

Additional Info

Field Value
Program Area Care and Treatment
Year 2019
Author
Author Email cmkandawire@hivmw.org